NasdaqGS - Nasdaq Real Time Price USD
Neumora Therapeutics, Inc. (NMRA)
0.8140
+0.0240
+(3.04%)
As of 1:28:43 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 7 | 7 |
| Avg. Estimate | -0.37 | -0.37 | -1.43 | -1.12 |
| Low Estimate | -0.44 | -0.46 | -1.79 | -1.77 |
| High Estimate | -0.33 | -0.3 | -0.86 | -0.36 |
| Year Ago EPS | -0.37 | -0.45 | -1.53 | -1.43 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 8 | 8 |
| Avg. Estimate | -- | -- | -- | 3.4M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 25M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.36 | -0.38 | -0.44 | -0.38 |
| EPS Actual | -0.37 | -0.45 | -0.37 | -0.42 |
| Difference | -0.01 | -0.07 | 0.07 | -0.04 |
| Surprise % | -3.48% | -18.33% | 16.34% | -10.04% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.37 | -0.37 | -1.43 | -1.12 |
| 7 Days Ago | -0.4 | -0.41 | -1.52 | -1.38 |
| 30 Days Ago | -0.4 | -0.41 | -1.52 | -1.38 |
| 60 Days Ago | -0.4 | -0.41 | -1.52 | -1.34 |
| 90 Days Ago | -0.44 | -0.4 | -1.6 | -1.41 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 4 | 4 | 4 | 4 |
| Up Last 30 Days | 4 | 4 | 4 | 4 |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | 1 | 1 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NMRA | -1.26% | 17.01% | 6.82% | 21.74% |
| S&P 500 | 13.12% | 2.46% | 7.55% | 13.98% |
Upgrades & Downgrades
| Reiterates | Needham: Buy to Buy | 5/13/2025 |
| Reiterates | Needham: Buy to Buy | 4/10/2025 |
| Downgrade | B of A Securities: Buy to Underperform | 4/2/2025 |
| Downgrade | Guggenheim: Buy to Neutral | 3/10/2025 |
| Downgrade | Stifel: Buy to Hold | 3/7/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/7/2025 |
Related Tickers
ALLO Allogene Therapeutics, Inc.
1.3150
+1.94%
DAWN Day One Biopharmaceuticals, Inc.
7.01
+1.08%
ACRV Acrivon Therapeutics, Inc.
1.2500
+1.63%
CRGX CARGO Therapeutics, Inc.
4.5950
+0.99%
QTTB Q32 Bio Inc.
1.8850
-2.33%
CTNM Contineum Therapeutics, Inc.
4.1500
-5.90%
GBIO Generation Bio Co.
0.3731
-3.69%
FATE Fate Therapeutics, Inc.
1.3793
-2.86%
CCCC C4 Therapeutics, Inc.
1.4699
-4.57%
IGMS IGM Biosciences, Inc.
1.2600
0.00%